Ernexa Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
Ernexa Therapeutics Inc. (ERNA) had Lessee, Operating Lease, Liability, to be Paid, Year Two of $95.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $95.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $95.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $200.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $200.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2026-06-30 | $95.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $95.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $200.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $173.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $163.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $267.00K 10-K · filed 2025-03-12 |
| 2024-09-30 | $267.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.24M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.24M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.08M 10-K · filed 2024-03-14 |
| 2023-09-30 | $6.07M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.07M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $274.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $272.00K 10-K · filed 2023-03-20 |
| 2022-09-30 | $688.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $688.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $272.00K 10-Q · filed 2022-07-01 |
| 2021-12-31 | $767.00K 10-K/A · filed 2022-07-01 |
| 2021-09-30 | $767.15K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $769.86K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $606.86K 10-Q · filed 2021-05-17 |
| 2020-06-30 | $8.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $613.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $620.00K 10-K · filed 2020-03-19 |
| 2019-09-30 | $635.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $633.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $615.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |